ELV · 10-Q · 2026Q2 · Full report

Operating Cash Flow Trends

Elevance Health, Inc. · 2026-07-15 · Importance 63 · Surprise 64 · In source text

Operating cash flow (net cash provided by operating activities) improved to $6,245 million for the six months ended June 30, 2026, from $3,071 million for the six months ended June 30, 2025, an increase of $3,174 million. The MD&A attributes the increase primarily to favorable working capital impacts, partially offset by lower shareholders’ net income in the six months ended June 30, 2026. The improvement in operating cash flow was realized in the six-month period ended June 30, 2026 and supports liquidity for ongoing investments and the Transformation Program.

Key facts

• Operating cash flow for the six months ended June 30, 2026 was $6,245 and for the six months ended June 30, 2025 was $3,071. source
• Net cash provided by operating activities for the six months ended June 30, 2026: $6,245 and for the six months ended June 30, 2025: $3,071, change $3,174. source
• Total sources of cash for the six months ended June 30, 2026: $6,313 and for the six months ended June 30, 2025: $4,052, change $2,261. source
• Purchases of investments, net of proceeds from sales, maturities, calls and redemptions for the six months ended June 30, 2026: $(813). source
• Changes in bank overdrafts (uses of cash) for the six months ended June 30, 2026: $(1,181). source

Impact estimates